Author: Fiona Craig
-

AMD and ARM Continue Winning Ground Over Intel in CPU Market – Bank of America
Advanced Micro Devices (NASDAQ:AMD) and ARM-based processors are steadily gaining market share from Intel (NASDAQ:INTC) across multiple segments, according to a Bank of America analysis covering Q2 2025. In the PC market, total CPU shipments rose 1% sequentially and 6% year-over-year following a seasonally slow start to the year. Intel’s shipments grew 2% quarter-over-quarter, while…
-

IEA Forecasts Stronger-Than-Expected Global Oil Supply in 2025
Global oil production is projected to expand more than anticipated in 2025, according to the International Energy Agency (IEA), following a decision by key producers to boost output. In its latest monthly report, the Paris-based organization raised its outlook for world oil supply to 2.5 million barrels per day (bpd) in 2025, up from an…
-

Retail Investors Shift Attention from Meme Stocks to Blue Chips – Goldman Sachs
Retail investors have recently increased their activity in S&P 500 and Nasdaq 100 stocks, broadening their focus from speculative meme stocks to more established large-cap companies, according to Goldman Sachs. Analysis from Goldman’s electronic trading desk indicates that among the 25 most-traded stocks by retail investors are familiar names like Palantir (NASDAQ:PLTR), AMD (NASDAQ:AMD), and…
-

UBS Analyzes Potential Impact of U.S. Tariffs on Retail Inflation
Investors in retail companies will likely keep pricing strategies under close scrutiny in the coming months, as markets evaluate whether sweeping U.S. tariffs are affecting consumer spending, according to UBS analysts. In a note led by Michael Lasser, the analysts said that recent inflation data suggest the impact of the tariffs has been “minimal,” despite…
-

Wolfe: Index Valuations Back at ‘Nosebleed Levels’ Amid Strong Q2 Earnings
The second-quarter 2025 earnings season is nearing its conclusion, and Wolfe Research analysts describe results as “very solid.” As of Monday, 452 S&P 500 companies had reported earnings, with “69% of companies beating expectations on the top-line with an aggregate dollar-weighted surprise of +2.8%,” according to Wolfe Research. On the bottom line, “80% of companies…
-

BofA: July e-commerce growth stays strong, early signs point positively for Amazon
Bank of America (BofA) reported Tuesday that the momentum in e-commerce sales persisted through July, with aggregated credit and debit card data showing total online spending up 7% year over year — matching June’s growth rate. In its research note, the bank highlighted that in-store sales slipped 1% during the same period, lifting online market…
-

Hedge Funds Rise 1.1% in July, Event-Driven Strategies Lead the Way
Hedge funds worldwide gained 1.1% in July, driven by event-driven managers and fundamental equity long/short funds, according to Goldman Sachs Prime Desk. Event-driven strategies saw the strongest performance, climbing 1.8% last month as increased merger arbitrage activity boosted returns. Fundamental equity long/short funds closely followed with a 1.6% gain. Despite these advances, both strategy types…
-

OPEC Sees Global Oil Demand Hitting 107.7 Million Barrels a Day by Late 2026
Global appetite for oil is set to keep climbing over the next two years, according to OPEC’s August oil market report, which projects demand will reach 107.7 million barrels per day (bpd) in the final quarter of 2026. That’s an increase from the 106.4 million bpd expected in the last quarter of 2025. The forecast…
-

Lexaria Bioscience Shares Rise After Reaching GLP-1 Study Milestone
Lexaria Bioscience Corp (NASDAQ:LEXX) stock climbed 3.4% following the announcement that the company has achieved a key milestone in its Phase 1b glucagon-like peptide-1 (GLP-1) study in Australia. The drug delivery platform developer confirmed that its Contract Research Organization (CRO) reached the last patient last visit (LPLV) milestone in the GLP-1-H24-4 trial, marking the completion…
-

Scienture Shares Plunge After $3.9 Million Discounted Offering Announcement
Scienture Holdings Inc (NASDAQ:SCNX) stock fell sharply, dropping 43.7%, after the company announced a registered direct offering of common stock at a steep discount to its current market price. The pharmaceutical holding company entered into a securities purchase agreement with institutional investors to sell 3,225,000 shares at $1.20 per share. The offering, expected to close…